Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Income (Loss)

v3.8.0.1
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenue $ 5,121,019 $ 2,606,670 $ 13,090,643 $ 5,879,514
Costs and expenses        
Selling expenses 3,126,025 1,087,112 9,037,176 3,401,572
General and administrative expenses 1,441,290 973,025 3,932,468 2,620,973
Total Costs and Expenses 4,567,315 2,060,137 12,969,644 6,022,545
Income (Loss) from Operations 553,704 546,533 120,999 (143,031)
Other Expenses (Income)        
Interest expense, net of interest income 110,391 209,556 360,778 515,051
Changes in fair value of derivative liabilities (108,750) 77,095 (245,445) (291,121)
Imputed interest on related party advances 8,248 3,492 22,535 6,060
Impairment on investment 186 6,758
Total Other Expenses (Income) 10,075 290,143 144,626 229,990
Income (Loss) before income taxes 543,629 256,390 (23,627) (373,021)
Income taxes provision 271,964 220,275 333,419 248,138
Net Income (Loss) 271,665 36,115 (357,046) (621,159)
Other Comprehensive Income (Loss)        
Foreign currency translation adjustment 43,259 4,814 6,666 (5,463)
Comprehensive Income (Loss) $ 314,924 $ 40,929 $ (350,380) $ (626,622)
Net Income (Loss) per common share - basic $ 0.01 $ 0.00 $ (0.01) $ (0.02)
Net Income (Loss) per common share - diluted $ 0.01 $ 0.00 $ (0.01) $ (0.02)
Weighted average number of common shares outstanding basic 37,009,295 30,362,394 37,009,295 26,298,527
Weighted average number of common shares outstanding diluted 37,552,008 31,488,116 37,009,295 26,298,527